Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAPT-STEMI: 6 vs 12 months dual antiplatelet therapy after second-generation drug-eluting stent implantation in STEMI
NL-OMON39800Phase 4Active, not recruiting
- Sponsor
- Maasstad Ziekenhuis
- Start
- Dec 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aspirin, prasugrel and ticagrelor in myocardial infarction (MI), sponsored by Maasstad Ziekenhuis. Primary endpoints: Registry primary endpoint and Resolute Integrity report primary endpoint. Started Dec 2011; status: active, not recruiting.
02
Drugs
aspirinprasugrelticagrelor
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON39800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39800.